SEC Form 4 · accession 0000914190-26-000116
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shane Bohnen
Officer — SVP - General Counsel
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 4:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2026 | M | 4,350 | $0.00 | A | 11,703 | D | |
| Common Stock | Aug 15, 2026 | F | 1,343 | $72.40 | D | 10,360 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F5 | — | Aug 15, 2026 | M | 49 | D | — | — | Common Stock | 49 | 0 | D |
| Performance Stock Option (Right to Buy)F6 | $84.61 | Aug 15, 2026 | D | 12,117 | D | — | — | Common Stock | 12,117 | 807 | D |
| Performance Restricted Stock UnitsF3,F7 | — | Aug 15, 2026 | M | 300 | D | — | — | Common Stock | 300 | 4,502 | D |
| Performance Restricted Stock UnitsF3,F7 | — | Aug 15, 2026 | D | 4,502 | D | — | — | Common Stock | 4,502 | 0 | D |
| Restricted Stock UnitsF3,F9 | — | Aug 15, 2026 | M | 1,669 | D | — | — | Common Stock | 1,669 | 1,669 | D |
| Restricted Stock UnitsF3,F12 | — | Aug 15, 2026 | M | 2,332 | D | — | — | Common Stock | 2,332 | 4,664 | D |
| Stock Option (Right to Buy)F1 | $66.97 | holding | — | — | — | — | Aug 5, 2027 | Common Stock | 8,944 | 8,944 | D |
| Stock Option (Right to Buy)F1 | $120.46 | holding | — | — | — | — | Aug 6, 2028 | Common Stock | 3,460 | 3,460 | D |
| Stock Option (Right to Buy)F1 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 3,508 | 3,508 | D |
| Stock Option (Right to Buy)F2 | $73.76 | holding | — | — | — | — | Apr 3, 2030 | Common Stock | 3,928 | 3,928 | D |
| Stock Option (Right to Buy)F4 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 16,302 | 16,302 | D |
| Performance Restricted Stock UnitsF3,F8 | — | holding | — | — | — | — | — | Common Stock | 10,012 | 10,012 | D |
| Stock Option (Right to Buy)F10 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 13,488 | 13,488 | D |
| Performance Restricted Stock UnitsF3,F11 | — | holding | — | — | — | — | — | Common Stock | 13,992 | 13,992 | D |
| Stock Option (Right to Buy)F13 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 17,897 | 17,897 | D |
Explanation of responses
- F1Fully exercisable.
- F10Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- F11Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F122,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F13Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.
- F2Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
- F3Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F4Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
- F549 restricted stock units vest on 8/15/2026.
- F6On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited.
- F7On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited.
- F8Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F91,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.